Apollo Hospitals Enterprise Ltd (APOLLOHOSP) Q1FY27 Concall Summary - Jun-2026 Qtr
Performance Overview
- The company reported a strong start to FY27, with double-digit revenue growth across all three business verticals: Healthcare Services, Apollo Health Co (AHC), and Apollo Health and Lifestyle Ltd (AHLL), demonstrating sustained demand across its integrated healthcare platform.
- Consolidated revenue grew by 21% YoY, and EBITDA increased by 28% YoY, leading to a margin improvement from 14.6% to 15.5%. This was driven by a combination of volume growth, improved case mix, and pricing adjustments.
- The Healthcare Services division saw robust performance with 22% YoY revenue growth, supported by an 11% increase in volumes, a 4% pricing increase, and a 3% improvement from the case mix.
- The digital health business, under Apollo Health Co, showed significant progress towards profitability, with the digital cash loss reducing to INR 10 crores from INR 49 crores in the previous year, and is on track to achieve break-even in the upcoming quarter.
- The company is advancing its capacity expansion program, with a new 180-bed facility in Sarjapur, Bangalore, becoming operational and a clear expansion plan laid out until FY31 to reach a total capacity of 14,100 beds, funded primarily through internal accruals.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.